Royal Biologics
PrivateLast Round
Early Funding
Jun 19, 2019
Company Overview
Royal Biologics is a medical devices company that manufactures and distributes orthobiologics, stem cell therapy devices, and spinal implant hardware.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Royal Biologics Comparables
Compare Royal Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PRP Concepts | 86% | |
| Isto Biologics | 81% | |
| Reapplix | 76% | |
Royal Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jun 19, 2019 |
Key People
Founding team and executive leadership
Royal Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Granite Creek Capital Partners | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2026
Monthly visitors grew 479% MoM, reaching 4K.
- May 4, 2025
Monthly visitors increased 50% MoM.
Royal Biologics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Royal Biologics's valuation, stock price, and market status.